The Board of Directors of Jeil Pharmaceutical Co., Ltd. (KOSE:A002620) authorized a share repurchase program on January 31, 2013. Under the program, the company will repurchase up to KRW 2 billion worth of own shares pursuant to a trust agreement with Sinhan Investment Corp. The purpose behind the program is to stabilize the stock price.

Repurchases will commence on February 1, 2013 and will continue until January 31, 2014. As of January 30, 2013, the company has 1,478,600 shares in directly owned treasury stock and 265,080 shares in treasury under trust agreement. Sinhan Investment Corp.

acted as the broker to the company.